Giulia Minniti
Overview
Explore the profile of Giulia Minniti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
52
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fornari Laurindo L, Dogani Rodrigues V, Minniti G, de Carvalho A, Zutin T, DeLiberto L, et al.
J Nutr Biochem
. 2024 Dec;
136:109793.
PMID: 39653462
No abstract available.
2.
Fornari Laurindo L, Minniti G, Dogani Rodrigues V, Fornari Laurindo L, Maria Cavallari Strozze Catharin V, Federighi Baisi Chagas E, et al.
Curr Med Chem
. 2024 Aug;
32(6):1168-1194.
PMID: 39206478
Introduction: Adiponectin replacement therapy shows promising outcomes in various diseases, especially for bone-related disorders. Challenges in using the complete protein have led to alternative approaches, with AdipoRon and AdipoAI emerging...
3.
Fornari Laurindo L, Dogani Rodrigues V, Minniti G, de Carvalho A, Zutin T, DeLiberto L, et al.
J Nutr Biochem
. 2024 May;
131:109670.
PMID: 38768871
Pomegranate (Punica granatum L.) is a multipurpose dietary and medicinal plant known for its ability to promote various health benefits. Metabolic syndrome (MetS) is a complex metabolic disorder driving health...
4.
L., By-Products, and Mangiferin on Cardio-Metabolic and Other Health Conditions: A Systematic Review
Minniti G, Fornari Laurindo L, Machado N, Duarte L, Landgraf Guiguer E, Cressoni Araujo A, et al.
Life (Basel)
. 2023 Dec;
13(12).
PMID: 38137871
Mango and its by-products have traditional medicinal uses. They contain diverse bioactive compounds offering numerous health benefits, including cardioprotective and metabolic properties. This study aimed to explore the impact of...
5.
Barbalho S, de Alvares Goulart R, Minniti G, Bechara M, de Castro M, Dias J, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2023 Nov;
397(5):2681-2699.
PMID: 37966572
Rho-associated kinases (ROCKs) are crucial during the adipocyte differentiation process. KD025 (Belumosudil) is a newly developed inhibitor that selectively targets ROCK2. It has exhibited consistent efficacy in impeding adipogenesis across...
6.
Barbalho S, Minniti G, Miola V, Dos Santos Haber J, Cincotto Dos Santos Bueno P, Santos de Argollo Haber L, et al.
Cells
. 2023 Jul;
12(10).
PMID: 37408184
Coronavirus disease 2019 (COVID-19) is a viral infection caused by SARS-CoV-2 that induces a generalized inflammatory state. Organokines (adipokines, osteokines, myokines, hepatokines, and cardiokines) can produce beneficial or harmful effects...
7.
Direito R, Barbalho S, Figueira M, Minniti G, de Carvalho G, de Oliveira Zanuso B, et al.
Metabolites
. 2023 Jun;
13(6).
PMID: 37367886
Ongoing research explores the underlying causes of ulcerative colitis and Crohn's disease. Many experts suggest that dysbiosis in the gut microbiota and genetic, immunological, and environmental factors play significant roles....
8.
Fornari Laurindo L, de Maio M, Minniti G, de Goes Correa N, Barbalho S, Quesada K, et al.
Metabolites
. 2023 Feb;
13(2).
PMID: 36837862
Inflammatory bowel diseases (IBDs) are related to nuclear factor erythroid 2-related factor 2 (Nrf2) dysregulation. In vitro and in vivo studies using phytocompounds as modulators of the Nrf2 signaling in...
9.
Minniti G, Pescinini-Salzedas L, Minniti G, Fornari Laurindo L, Barbalho S, Sinatora R, et al.
Int J Mol Sci
. 2022 Nov;
23(21).
PMID: 36362238
Sarcopenia is a disease that becomes more prevalent as the population ages, since it is directly linked to the process of senility, which courses with muscle atrophy and loss of...